View Older Stories View More Recent Stories

Apr 26, 2022 05:18PM SCYNEXIS Announces Closing of $45 Million Public Offering of Common Stock, Pre-Funded Warrants and Warrants
Apr 26, 2022 04:11PM Sono Group (SEV) Announces 10M Share Follow-on Offering
Apr 26, 2022 04:10PM Sono Motors Announces Follow-on Offering
Apr 26, 2022 04:10PM Sono Motors Announces Follow-on Offering
Apr 26, 2022 10:46AM Form SC 13G Arbor Rapha Capital Bioh Filed by: CANTOR FITZGERALD SECURITIES
Apr 26, 2022 08:51AM Cantor Fitzgerald Reiterates Overweight Rating, $7 Price Target on VolitionRX (VNRX)
Apr 26, 2022 08:05AM B. Riley Securities Expands Fixed Income Division with Two Key Managing Director Hires, Ji Pak and Mary Jo Collins
Apr 22, 2022 05:20PM Form N-2/A CANTOR FITZGERALD SUSTAI
Apr 22, 2022 08:17AM Scynexis (SCYX) Prices $45M Stock and Warrant Offering at $3/sh
Apr 22, 2022 08:15AM SCYNEXIS Announces Pricing of $45 Million Public Offering of Common Stock, Pre-Funded Warrants and Warrants
Apr 22, 2022 06:18AM SeaSpine Holdings (SPNE) PT Lowered to $21 at Cantor Fitzgerald on Lower Guidance, but Analyst Reiterates "Overweight", Encourages "Investors to Acquire SPNE's Shares at Attractive Valuation"
Apr 21, 2022 04:00PM Piper Sandler Expands Fixed Income Platform With Several Key Hires
Apr 20, 2022 06:36AM Marinus Pharmaceuticals (MRNS) PT Raised to $28 at Cantor Fitzgerald
Apr 19, 2022 01:32PM Form 424B3 Cantor Fitzgerald Income
Apr 19, 2022 12:04PM Form 8-K Cantor Fitzgerald Income For: Apr 14
Apr 19, 2022 08:00AM Brightwood Announces Appointment of Frederick Jelks and Chris Halajian as Directors
Apr 19, 2022 07:37AM Johnson & Johnson (JNJ) Shares Dip After Revenue Miss, Suspended COVID Vaccine Sales Guidance; Results Seen as 'Mixed'
Apr 18, 2022 04:01PM Crinetics Pharmaceuticals Announces Closing of Underwritten Common Stock Offering
Apr 18, 2022 04:01PM Crinetics Pharmaceuticals Announces Closing of Underwritten Common Stock Offering
Apr 13, 2022 04:50PM Orchid Island Capital Announces Estimated First Quarter 2022 Results, April 2022 Monthly Dividend and March 31, 2022 RMBS Portfolio Characteristics
Apr 13, 2022 06:06AM Form 13F-HR CANTOR FITZGERALD INVEST For: Mar 31
Apr 13, 2022 05:39AM Crinetics Pharmaceuticals (CRNX) Prices 5.63M Share Offering at $22.22/sh
Apr 12, 2022 11:50PM Crinetics Pharmaceuticals Announces Pricing of Underwritten Common Stock Offering
Apr 12, 2022 11:50PM Crinetics Pharmaceuticals Announces Pricing of Underwritten Common Stock Offering
Apr 12, 2022 10:10AM David Pett Joins RAS Realty Partners as Managing Director
Apr 12, 2022 09:27AM TeraWulf (WULF) Prices $20.6 Million Public Offering of Common Stock
Apr 12, 2022 09:26AM TeraWulf Inc. Announces Pricing of $20.6 Million Public Offering of Common Stock
Apr 12, 2022 08:16AM Cantor Fitzgerald Reiterates Overweight Rating, $95 Price Target on I-Mab (IMAB), Expects "Greater Appreciation for the Company's Pipeline"
Apr 12, 2022 08:11AM BioCardia (BCDA) Enters $10.5M Stock Sales Agreement with Cantor Fitzgerald
Apr 12, 2022 05:53AM Heron Therapeutics (HRTX) and Omeros (OMER) Top Cantor Fitzgerald's Most Shorted List; Clarus (CRXT) and United Therapeutics (UTHR) Seeing Biggest Short Interest Increases
Apr 11, 2022 05:20PM TeraWulf (WULF) Announces Proposed Public Offering of Common Stock
Apr 11, 2022 05:20PM TeraWulf Inc. Announces Proposed Public Offering of Common Stock
Apr 11, 2022 02:21PM SCHWAZZE ANNOUNCES PARTICIPATION IN UPCOMING CONFERENCES & EVENTS
Apr 11, 2022 06:23AM Pfizer's (PFE) Paxlovid and Comirnaty Q1 Sales Estimates Lowered at Cantor Fitzgerald, but "Positive Investment Thesis" Maintained, Reiterates Overweight Rating
Apr 8, 2022 06:38AM Aptinyx (APTX) PT Lowered to $5 at Cantor Fitzgerald
Apr 8, 2022 06:09AM Cantor Fitzgerald Reiterates Overweight Rating and $335 PT on Eli Lilly (LLY), Sees CMS Decision "Better Than Anticipated" For LLY
Apr 8, 2022 05:57AM UPDATE: Cantor Fitzgerald Starts StoneCo Ltd. (STNE) at Overweight
Apr 8, 2022 05:57AM UPDATE: Cantor Fitzgerald Starts PagSeguro (PAGS) at Overweight
Apr 7, 2022 05:02PM Form 8-K Cantor Fitzgerald Income For: Apr 04
Apr 7, 2022 11:00AM Realto Hires Two Key Sales Professionals, Works to Build Upon Early Trading Success
Apr 7, 2022 09:08AM Cantor Fitzgerald Reiterates VYNE Therapeutics (VYNE) at Overweight with $10 PT, Sees Latest FMX114 Data Underscoring "Positive Investment Thesis"
Apr 7, 2022 07:14AM UPDATE: Cantor Fitzgerald Assumes Bicycle Therapeutics (BCYC) at Overweight
Apr 7, 2022 07:00AM Agrify to Be Featured on Industry Panel at the Cantor Fitzgerald 2nd Virtual US Cannabis Conference
Apr 7, 2022 06:19AM Cantor Fitzgerald Reiterates Overweight Rating, $75 Price Target on Pfizer (PFE), Sees Strong Pipeline and M&A Potential Driving PFE Higher
Apr 7, 2022 06:17AM UPDATE: Cantor Fitzgerald Assumes SI-BONE Inc. (SIBN) at Overweight, "Encourage Investors to Acquire Shares at Current Attractive Valuation" (CORRECTION)
Apr 6, 2022 10:41AM Tilray (TLRY) PT Raised to $8.40 at Cantor Fitzgerald
Apr 6, 2022 09:01AM Westrock Coffee Company to go Public Via Merger with Riverview Acquisition (RVAC)
Apr 6, 2022 09:00AM The Stephens Group Portfolio Investment Westrock Coffee Company, a Leading Integrated Coffee, Tea, Flavors, Extracts, and Ingredients Solutions Provider, to Become a Public Company Through Business Co
Apr 6, 2022 06:13AM Cantor Fitzgerald Reiterates Fortress Biotech (FBIO) at Overweight, $6 PT, "Upward Earnings Estimate Revisions and Multiple Expansion will Drive FBIO's Stock Higher"
Apr 5, 2022 01:28PM Merck's "Growth Growth Prospects in 2028+ are Underappreciate - Cantor Fitzgerald Reiterates Merck (MRK) at Overweight with $107 Price Target
View More Recent Stories View Older Stories